ÌÇÐÄvlog

This randomized clinical trial evaluates the efficacy and safety of first-line toripalimab vs placebo plus etoposide and platinum-based chemotherapy for treating patients with extensive-stage small cell lung cancer.

This cohort study investigates the regulatory fate in the European Union for drugs that received accelerated approval for cancer indications in the US.

This Special Communication proposes building regional technology transfer hubs, streamlining and increasing the use of compulsory licenses, and enhancing price transparency as a way to meaningfully reduce cancer drug prices globally, especially for low- and middle-income countries.

This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.

This phase 1b/2 nonrandomized clinical trial evaluates whether equecabtagene autoleucel can benefit patients with relapsed or refractory multiple myeloma and determines the overall response rate after infusion.

This Viewpoint highlights financial toxicity specific to Asian American cancer survivors and presents steps forward within the framework of the social ecological model of health, considering individual, interpersonal, community, and policy-level dimensions.